Skip to main content
Fig. 2 | Cell & Bioscience

Fig. 2

From: Engineered clinical-grade mesenchymal stromal cells combating SARS-CoV-2 omicron variants by secreting effective neutralizing antibodies

Fig. 2

Binding affility of three kinds of neutralizing mAbs, 2–15, XGv347, and LY-CoV1404 to SARS-CoV-2 S1 and RBD mutants. (a) Three neutralizing mAbs secreted by 293T cells bound to SARS-CoV-2 S1 and RBD mutants including BA.1, BA.2, BA.3, and BA.4/5 by ELISA (mean ± SD). (b) The mAbs secreted by the top 18 neutralizing MSCs clones bound to SARS-CoV-2 S1 and RBD mutants including BA.1, BA.2, BA.3, and BA.4/5 in ELISA (mean ± SD).

Back to article page

Cell & Bioscience

ISSN: 2045-3701

Contact us